taurine has been researched along with Epilepsies, Partial in 9 studies
Epilepsies, Partial: Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amino acid analysis of plasma and urine obtained from 12 patients with epilepsy indicated that the plasma concentrations of taurine and glutamic acid were much higher than might have been expected." | 7.65 | Biochemical observations following administration of taurine to patients with epilepsy. ( Anderman, F; Sacks, C; Sherwin, AL; Van Gelder, NM, 1975) |
| "Amino acid analysis of plasma and urine obtained from 12 patients with epilepsy indicated that the plasma concentrations of taurine and glutamic acid were much higher than might have been expected." | 3.65 | Biochemical observations following administration of taurine to patients with epilepsy. ( Anderman, F; Sacks, C; Sherwin, AL; Van Gelder, NM, 1975) |
| "Vigabatrin is an irreversible inhibitor of γ-aminobutyric acid (GABA) transaminase." | 2.47 | Understanding and interpreting vision safety issues with vigabatrin therapy. ( Plant, GT; Sergott, RC, 2011) |
| "Glycine content was elevated markedly in some foci, whereas aspartic acid content was normal." | 1.26 | Amino acid abnormalities in epileptogenic foci. ( Hansen, S; Perry, TL, 1981) |
| " This has been correlated with the effect of repeated oral dosing on the manifestations of cobalt-induced epilepsy in the rat." | 1.26 | Uptake studies of taurine in vivo and its effects on the course of experimental focal epilepsy in rats. ( Bradford, HF; Davison, AN; Osborne, RH; Wheler, GH, 1977) |
| "Glycine content was markedly elevated in two of 16 epileptogenic foci." | 1.25 | Amino acids in human epileptogenic foci. ( Hansen, S; Kennedy, J; Perry, TL; Thompson, GB; Wada, JA, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plant, GT | 1 |
| Sergott, RC | 1 |
| Perry, TL | 2 |
| Hansen, S | 2 |
| Fariello, RG | 1 |
| Durelli, L | 1 |
| Mutani, R | 1 |
| Quattrocolo, G | 1 |
| Delsedime, M | 1 |
| Buffa, C | 1 |
| Fassio, F | 1 |
| Valentini, C | 1 |
| Fumero, S | 1 |
| Wheler, GH | 1 |
| Osborne, RH | 1 |
| Bradford, HF | 1 |
| Davison, AN | 1 |
| Van Gelder, NM | 3 |
| Sherwin, AL | 2 |
| Sacks, C | 1 |
| Anderman, F | 1 |
| Kennedy, J | 1 |
| Wada, JA | 1 |
| Thompson, GB | 1 |
| Rasmussen, T | 1 |
| Courtois, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study in Adolescents With Bipolar Disorder[NCT00391001] | Phase 1 | 4 participants (Actual) | Interventional | 2006-02-28 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for taurine and Epilepsies, Partial
| Article | Year |
|---|---|
Understanding and interpreting vision safety issues with vigabatrin therapy.
Topics: 4-Aminobutyrate Transaminase; Adult; Animals; Anticonvulsants; Causality; Comorbidity; Confounding F | 2011 |
8 other studies available for taurine and Epilepsies, Partial
| Article | Year |
|---|---|
Amino acid abnormalities in epileptogenic foci.
Topics: Adolescent; Adult; Aged; Amino Acids; Aspartic Acid; Cerebral Cortex; Child; Epilepsies, Partial; Fr | 1981 |
Action of inhibitory amino acids on acute epileptic foci: an electrographic study.
Topics: Animals; beta-Alanine; Blood Pressure; Cats; Electroencephalography; Epilepsies, Partial; Female; ga | 1979 |
Relationships between electroencephalographic pattern and biochemical picture of the cobalt epileptogenic lesion after cortical superfusion with taurine.
Topics: Amino Acids; Animals; Anticonvulsants; Cats; Cerebral Cortex; Cobalt; Disease Models, Animal; Drug E | 1977 |
Uptake studies of taurine in vivo and its effects on the course of experimental focal epilepsy in rats.
Topics: Animals; Blood-Brain Barrier; Cerebral Cortex; Cobalt; Disease Models, Animal; Drug Evaluation, Prec | 1977 |
Biochemical observations following administration of taurine to patients with epilepsy.
Topics: Adolescent; Adult; Alanine; Anticonvulsants; Aspartic Acid; Cerebral Cortex; Child; Child, Preschool | 1975 |
Amino acids in human epileptogenic foci.
Topics: Adolescent; Adult; Amino Acids; Animals; Aspartic Acid; Cerebral Cortex; Child; Cystathionine; Epile | 1975 |
Amino acid content of epileptogenic human brain: focal versus surrounding regions.
Topics: Adolescent; Adult; Alanine; Amino Acids; Aminobutyrates; Aspartic Acid; Brain; Cerebral Cortex; Chil | 1972 |
Close correlation between changing content of specific amino acids in epileptogenic cortex of cats, and severity of epilepsy.
Topics: Alanine; Amino Acids; Aminobutyrates; Animals; Aspartic Acid; Cats; Cerebral Cortex; Cobalt; Electro | 1972 |